Search results
Earnings call: ChipMOS reports mixed Q1 results, optimistic about H2 2024
Investing.com· 2 days agoChipMOS TECHNOLOGIES INC. (IMOS) has released its financial results for the first quarter of 2024,...
Earnings call: Electrovaya reports a revenue increase of 26% By Investing.com
Investing.com· 42 minutes agoElectrovaya Inc. (EFL.TO) has reported a significant year-over-year revenue increase of 26% in its...
Earnings call: InnovAge posts modest growth amid challenges
Investing.com· 2 days agoDespite facing temporary headwinds like enrollment processing delays in Colorado and a competitive...
Earnings call: Cellectar Biosciences outlines robust WM market strategy
Investing.com· 19 hours agoCellectar Biosciences (NASDAQ: CLRB ) has reported its first-quarter financial results and provided...
Earnings call: Y-mAbs Therapeutics reports mixed Q1 results, growth in DANYELZA sales
Investing.com· 6 days agoY-mAbs Therapeutics Inc. (ticker: YMAB) has reported an 11% increase in net sales for their flagship...
Earnings call: Amicus Therapeutics highlights solid Q1 growth, raises guidance
Investing.com· 5 days agoAmicus (NASDAQ: FOLD ) Therapeutics ( NASDAQ : FOLD) has reported a strong start to 2024 with a 28%...
Earnings call: Anika reports revenue growth and strategic advancements in Q1 2024
Investing.com· 6 days agoAnika Therapeutics Inc. (NASDAQ: ANIK ), a leader in regenerative medicine, reported a solid first...
Earnings call: FIGS maintains resilience with mixed Q1 results, plans growth
Investing.com· 4 days agoFIGS, the healthcare apparel brand, reported a slight dip in its first-quarter 2024 net revenues,...
Earnings call: Rockwell Medical reports growth and optimistic 2024 outlook By Investing.com
Investing.com· 8 hours agoRockwell Medical Inc. (RMTI) has released its Q1 2024 financial results, showcasing a positive...
McDonald’s is focused on affordability. What we know after reports of $5 meal deals.
USA Today· 1 day agoMcDonald's is seemingly fighting to attract customers one deal at a time. McDonald's has faced...